Anteris Technologies Global Corp. (AVR) vs Candel Therapeutics, Inc. (CADL)
A side-by-side comparison of Anteris Technologies Global Corp. and Candel Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVR
Anteris Technologies Global Corp.
$7.55HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CADL
Candel Therapeutics, Inc.
$10.23HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — AVR vs CADL
growth of $100 · dividends reinvested · last 2yAVR +34.8% (+16.1%/yr)CADL +51.6% (+23.1%/yr)CADL compounded faster over this window
AVR CADL
AVR vs CADL: by the numbers
- •CADL is the larger company ($750M vs $734M market cap).
- •Both run net losses; CADL's is the smaller (0.00% vs -4619.67% net margin).
Metrics side by side
Valuation
| Metric | AVR | CADL |
|---|---|---|
| P/S ratio | 327.43 | N/A |
| P/B ratio | 2.92 | 5.94 |
Profitability
| Metric | AVR | CADL |
|---|---|---|
| Gross margin | -16.57% | 0.00% |
| Operating margin | -4908.21% | 0.00% |
| Net margin | -4619.67% | 0.00% |
| ROE | -41.20% | -70.19% |
| ROIC | -41.63% | -36.83% |
Growth (annualized)
| Metric | AVR | CADL |
|---|---|---|
| Revenue CAGR (5Y) | -18.92% | N/A |
| Total return CAGR (5Y) | N/A | -1.42% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.